{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,25]],"date-time":"2026-06-25T11:15:32Z","timestamp":1782386132562,"version":"3.54.5"},"reference-count":41,"publisher":"Springer Science and Business Media LLC","issue":"5","license":[{"start":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T00:00:00Z","timestamp":1554076800000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Pharm Res"],"published-print":{"date-parts":[[2019,5]]},"DOI":"10.1007\/s11095-019-2613-8","type":"journal-article","created":{"date-parts":[[2019,4,1]],"date-time":"2019-04-01T15:04:46Z","timestamp":1554131086000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":33,"title":["Direct Drug Delivery of Low-Permeable Compounds to the Central Nervous System Via Intranasal Administration in Rats and Monkeys"],"prefix":"10.1007","volume":"36","author":[{"ORCID":"https:\/\/orcid.org\/0000-0001-5339-8372","authenticated-orcid":false,"given":"Shinji","family":"Iwasaki","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Syunsuke","family":"Yamamoto","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Noriyasu","family":"Sano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kimio","family":"Tohyama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yohei","family":"Kosugi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Atsutoshi","family":"Furuta","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Teruki","family":"Hamada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tomoko","family":"Igari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yasushi","family":"Fujioka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hideki","family":"Hirabayashi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nobuyuki","family":"Amano","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2019,4,1]]},"reference":[{"key":"2613_CR1","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"Crowe TP, Greenlee MHW, Kanthasamy AG, Hsu WH. Mechanism of intranasal drug delivery directly to the brain. Life Sci. 2018;195:44\u201352.","journal-title":"Life Sci"},{"issue":"1","key":"2613_CR2","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1602\/neurorx.2.1.3","volume":"2","author":"WM Pardridge","year":"2005","unstructured":"Pardridge WM. The blood-brain barrier: bottleneck in brain drug development. NeuroRx. 2005;2(1):3\u201314.","journal-title":"NeuroRx."},{"issue":"2","key":"2613_CR3","doi-asserted-by":"publisher","first-page":"75","DOI":"10.3109\/10717544.2013.838713","volume":"21","author":"D Mittal","year":"2014","unstructured":"Mittal D, Ali A, Md S, Baboota S, Sahni JK, Ali J. Insights into direct nose to brain delivery: current status and future perspective. Drug Deliv. 2014;21(2):75\u201386.","journal-title":"Drug Deliv"},{"key":"2613_CR4","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1016\/j.jconrel.2018.05.011","volume":"281","author":"M Agrawal","year":"2018","unstructured":"Agrawal M, Saraf S, Saraf S, Antimisiaris SG, Chougule MB, Shoyele SA, et al. Nose-to-brain drug delivery: an update on clinical challenges and progress towards approval of anti-Alzheimer drugs. J Control Release. 2018;281:139\u201377.","journal-title":"J Control Release"},{"issue":"1","key":"2613_CR5","doi-asserted-by":"publisher","first-page":"29","DOI":"10.1001\/archneurol.2011.233","volume":"69","author":"S Craft","year":"2012","unstructured":"Craft S, Baker LD, Montine TJ, Minoshima S, Watson GS, Claxton A, et al. Intranasal insulin therapy for Alzheimer disease and amnestic mild cognitive impairment: a pilot clinical trial. Arch Neurol. 2012;69(1):29\u201338.","journal-title":"Arch Neurol"},{"issue":"4","key":"2613_CR6","doi-asserted-by":"publisher","first-page":"1654","DOI":"10.1002\/jps.21924","volume":"99","author":"SV Dhuria","year":"2010","unstructured":"Dhuria SV, Hanson LR, Frey WH 2nd. Intranasal delivery to the central nervous system: mechanisms and experimental considerations. J Pharm Sci. 2010;99(4):1654\u201373.","journal-title":"J Pharm Sci"},{"issue":"5","key":"2613_CR7","doi-asserted-by":"publisher","first-page":"379","DOI":"10.1111\/j.2042-7158.1995.tb05814.x","volume":"47","author":"T Sakane","year":"1995","unstructured":"Sakane T, Akizuki M, Taki Y, Yamashita S, Sezaki H, Nadai T. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the molecular weight of drugs. J Pharm Pharmacol. 1995;47(5):379\u201381.","journal-title":"J Pharm Pharmacol"},{"issue":"9","key":"2613_CR8","doi-asserted-by":"publisher","first-page":"2456","DOI":"10.1248\/cpb.39.2456","volume":"39","author":"T Sakane","year":"1991","unstructured":"Sakane T, Akizuki M, Yamashita S, Nadai T, Hashida M, Sezaki H. The transport of a drug to the cerebrospinal fluid directly from the nasal cavity: the relation to the lipophilicity of the drug. Chem Pharm Bull (Tokyo). 1991;39(9):2456\u20138.","journal-title":"Chem Pharm Bull (Tokyo)"},{"issue":"5","key":"2613_CR9","doi-asserted-by":"publisher","first-page":"378","DOI":"10.1111\/j.2042-7158.1994.tb03817.x","volume":"46","author":"T Sakane","year":"1994","unstructured":"Sakane T, Akizuki M, Yamashita S, Sezaki H, Nadai T. Direct drug transport from the rat nasal cavity to the cerebrospinal fluid: the relation to the dissociation of the drug. J Pharm Pharmacol. 1994;46(5):378\u20139.","journal-title":"J Pharm Pharmacol"},{"issue":"10","key":"2613_CR10","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1124\/dmd.110.034611","volume":"38","author":"MB Genter","year":"2010","unstructured":"Genter MB, Krishan M, Augustine LM, Cherrington NJ. Drug transporter expression and localization in rat nasal respiratory and olfactory mucosa and olfactory bulb. Drug Metab Dispos. 2010;38(10):1644\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"2","key":"2613_CR11","doi-asserted-by":"publisher","first-page":"180","DOI":"10.1016\/j.neulet.2011.10.018","volume":"505","author":"N Thiebaud","year":"2011","unstructured":"Thiebaud N, Menetrier F, Belloir C, Minn AL, Neiers F, Artur Y, et al. Expression and differential localization of xenobiotic transporters in the rat olfactory neuro-epithelium. Neurosci Lett. 2011;505(2):180\u20135.","journal-title":"Neurosci Lett"},{"issue":"5","key":"2613_CR12","doi-asserted-by":"publisher","DOI":"10.1371\/journal.pone.0036167","volume":"7","author":"A Molinas","year":"2012","unstructured":"Molinas A, Sicard G, Jakob I. Functional evidence of multidrug resistance transporters (MDR) in rodent olfactory epithelium. PLoS One. 2012;7(5):e36167.","journal-title":"PLoS One"},{"issue":"8","key":"2613_CR13","doi-asserted-by":"publisher","first-page":"1225","DOI":"10.1023\/A:1025053115583","volume":"20","author":"CL Graff","year":"2003","unstructured":"Graff CL, Pollack GM. P-glycoprotein attenuates brain uptake of substrates after nasal instillation. Pharm Res. 2003;20(8):1225\u201330.","journal-title":"Pharm Res"},{"issue":"Pt B","key":"2613_CR14","doi-asserted-by":"publisher","first-page":"298","DOI":"10.1016\/j.brainres.2015.07.005","volume":"1628","author":"H Qosa","year":"2015","unstructured":"Qosa H, Miller DS, Pasinelli P, Trotti D. Regulation of ABC efflux transporters at blood-brain barrier in health and neurological disorders. Brain Res. 2015;1628(Pt B):298\u2013316.","journal-title":"Brain Res"},{"issue":"6","key":"2613_CR15","doi-asserted-by":"publisher","first-page":"449","DOI":"10.1111\/j.2042-7158.1991.tb03510.x","volume":"43","author":"T Sakane","year":"1991","unstructured":"Sakane T, Akizuki M, Yoshida M, Yamashita S, Nadai T, Hashida M, et al. Transport of cephalexin to the cerebrospinal fluid directly from the nasal cavity. J Pharm Pharmacol. 1991;43(6):449\u201351.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2613_CR16","doi-asserted-by":"publisher","first-page":"565","DOI":"10.1007\/s11095-006-9534-z","volume":"23","author":"UE Westin","year":"2006","unstructured":"Westin UE, Bostrom E, Grasjo J, Hammarlund-Udenaes M, Bjork E. Direct nose-to-brain transfer of morphine after nasal administration to rats. Pharm Res. 2006;23(3):565\u201372.","journal-title":"Pharm Res"},{"issue":"3","key":"2613_CR17","doi-asserted-by":"publisher","first-page":"679","DOI":"10.1124\/jpet.108.149807","volume":"330","author":"LR Hanson","year":"2009","unstructured":"Hanson LR, Roeytenberg A, Martinez PM, Coppes VG, Sweet DC, Rao RJ, et al. Intranasal deferoxamine provides increased brain exposure and significant protection in rat ischemic stroke. J Pharmacol Exp Ther. 2009;330(3):679\u201386.","journal-title":"J Pharmacol Exp Ther"},{"issue":"9","key":"2613_CR18","doi-asserted-by":"publisher","first-page":"3374","DOI":"10.1080\/10717544.2016.1183721","volume":"23","author":"RM Abd-Elal","year":"2016","unstructured":"Abd-Elal RM, Shamma RN, Rashed HM, Bendas ER. Trans-nasal zolmitriptan novasomes: in-vitro preparation, optimization and in-vivo evaluation of brain targeting efficiency. Drug Deliv. 2016;23(9):3374\u201386.","journal-title":"Drug Deliv"},{"issue":"1","key":"2613_CR19","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1211\/0022357022539","volume":"56","author":"L Illum","year":"2004","unstructured":"Illum L. Is nose-to-brain transport of drugs in man a reality? J Pharm Pharmacol. 2004;56(1):3\u201317.","journal-title":"J Pharm Pharmacol"},{"issue":"3","key":"2613_CR20","doi-asserted-by":"publisher","first-page":"133","DOI":"10.2165\/00126839-200708030-00001","volume":"8","author":"FW Merkus","year":"2007","unstructured":"Merkus FW, van den Berg MP. Can nasal drug delivery bypass the blood-brain barrier?: questioning the direct transport theory. Drugs R D. 2007;8(3):133\u201344.","journal-title":"Drugs R D"},{"key":"2613_CR21","doi-asserted-by":"publisher","first-page":"20","DOI":"10.1159\/000321044","volume":"40","author":"C Bitter","year":"2011","unstructured":"Bitter C, Suter-Zimmermann K, Surber C. Nasal drug delivery in humans. Curr Probl Dermatol. 2011;40:20\u201335.","journal-title":"Curr Probl Dermatol"},{"issue":"3","key":"2613_CR22","doi-asserted-by":"publisher","first-page":"329","DOI":"10.1016\/0169-409X(93)90015-V","volume":"11","author":"S Gizurarson","year":"1993","unstructured":"Gizurarson S. The relevance of nasal physiology to the design of drug absorption studies. Adv Drug Deliv Rev. 1993;11(3):329\u201347.","journal-title":"Adv Drug Deliv Rev"},{"issue":"3","key":"2613_CR23","doi-asserted-by":"publisher","first-page":"371","DOI":"10.1038\/jcbfm.2014.215","volume":"35","author":"JJ Lochhead","year":"2015","unstructured":"Lochhead JJ, Wolak DJ, Pizzo ME, Thorne RG. Rapid transport within cerebral perivascular spaces underlies widespread tracer distribution in the brain after intranasal administration. J Cereb Blood Flow Metab. 2015;35(3):371\u201381.","journal-title":"J Cereb Blood Flow Metab"},{"issue":"4","key":"2613_CR24","doi-asserted-by":"publisher","first-page":"383 e1","DOI":"10.1016\/j.ajog.2010.01.035","volume":"202","author":"SJ Hemauer","year":"2010","unstructured":"Hemauer SJ, Patrikeeva SL, Nanovskaya TN, Hankins GD, Ahmed MS. Role of human placental apical membrane transporters in the efflux of glyburide, rosiglitazone, and metformin. Am J Obstet Gynecol. 2010;202(4):383 e1\u20137.","journal-title":"Am J Obstet Gynecol"},{"issue":"5","key":"2613_CR25","doi-asserted-by":"publisher","first-page":"655","DOI":"10.1211\/jpp.59.5.0005","volume":"59","author":"L Yu","year":"2007","unstructured":"Yu L, Zeng S. Transport characteristics of zolmitriptan in a human intestinal epithelial cell line Caco-2. J Pharm Pharmacol. 2007;59(5):655\u201360.","journal-title":"J Pharm Pharmacol"},{"issue":"12","key":"2613_CR26","doi-asserted-by":"publisher","first-page":"1282","DOI":"10.1124\/dmd.117.077883","volume":"45","author":"J Bicker","year":"2017","unstructured":"Bicker J, Fortuna A, Alves G, Soares-da-Silva P, Falcao A. Elucidation of the impact of P-glycoprotein and breast Cancer resistance protein on the brain distribution of catechol-O-methyltransferase inhibitors. Drug Metab Dispos. 2017;45(12):1282\u201391.","journal-title":"Drug Metab Dispos"},{"issue":"1","key":"2613_CR27","doi-asserted-by":"publisher","first-page":"65","DOI":"10.1208\/s12248-014-9668-6","volume":"17","author":"Q Mao","year":"2015","unstructured":"Mao Q, Unadkat JD. Role of the breast cancer resistance protein (BCRP\/ABCG2) in drug transport--an update. AAPS J. 2015;17(1):65\u201382.","journal-title":"AAPS J"},{"key":"2613_CR28","doi-asserted-by":"publisher","first-page":"403","DOI":"10.1007\/978-3-642-14541-4_11","volume":"201","author":"S Oswald","year":"2011","unstructured":"Oswald S, Terhaag B, Siegmund W. In vivo probes of drug transport: commonly used probe drugs to assess function of intestinal P-glycoprotein (ABCB1) in humans. Handb Exp Pharmacol. 2011;201:403\u201347.","journal-title":"Handb Exp Pharmacol"},{"issue":"2","key":"2613_CR29","doi-asserted-by":"publisher","first-page":"574","DOI":"10.1124\/jpet.102.038521","volume":"303","author":"K Lee","year":"2002","unstructured":"Lee K, Ng C, Brouwer KL, Thakker DR. Secretory transport of ranitidine and famotidine across Caco-2 cell monolayers. J Pharmacol Exp Ther. 2002;303(2):574\u201380.","journal-title":"J Pharmacol Exp Ther"},{"issue":"2","key":"2613_CR30","doi-asserted-by":"publisher","first-page":"265","DOI":"10.1124\/dmd.110.034629","volume":"39","author":"X Lin","year":"2011","unstructured":"Lin X, Skolnik S, Chen X, Wang J. Attenuation of intestinal absorption by major efflux transporters: quantitative tools and strategies using a Caco-2 model. Drug Metab Dispos. 2011;39(2):265\u201374.","journal-title":"Drug Metab Dispos"},{"key":"2613_CR31","doi-asserted-by":"publisher","first-page":"3873","DOI":"10.1007\/s00204-017-2008-8","volume":"91","author":"M Bai","year":"2017","unstructured":"Bai M, Ma Z, Sun D, Zheng C, Weng Y, Yang X, et al. Multiple drug transporters mediate the placental transport of sulpiride. Arch Toxicol. 2017;91:3873\u201384.","journal-title":"Arch Toxicol"},{"issue":"7","key":"2613_CR32","doi-asserted-by":"publisher","first-page":"1230","DOI":"10.1124\/dmd.109.029322","volume":"38","author":"K Kadono","year":"2010","unstructured":"Kadono K, Akabane T, Tabata K, Gato K, Terashita S, Teramura T. Quantitative prediction of intestinal metabolism in humans from a simplified intestinal availability model and empirical scaling factor. Drug Metab Dispos. 2010;38(7):1230\u20137.","journal-title":"Drug Metab Dispos"},{"issue":"7","key":"2613_CR33","doi-asserted-by":"publisher","first-page":"1121","DOI":"10.1007\/s11095-005-5420-3","volume":"22","author":"KK Kandimalla","year":"2005","unstructured":"Kandimalla KK, Donovan MD. Localization and differential activity of P-glycoprotein in the bovine olfactory and nasal respiratory mucosae. Pharm Res. 2005;22(7):1121\u20138.","journal-title":"Pharm Res"},{"issue":"3","key":"2613_CR34","doi-asserted-by":"publisher","first-page":"248","DOI":"10.2133\/dmpk.DMPK-10-RG-108","volume":"26","author":"T Shingaki","year":"2011","unstructured":"Shingaki T, Hidalgo IJ, Furubayashi T, Sakane T, Katsumi H, Yamamoto A, et al. Nasal delivery of P-gp substrates to the brain through the nose-brain pathway. Drug Metab Pharmacokinet. 2011;26(3):248\u201355.","journal-title":"Drug Metab Pharmacokinet"},{"issue":"12","key":"2613_CR35","doi-asserted-by":"publisher","first-page":"2355","DOI":"10.2174\/138920112803341752","volume":"13","author":"A Misra","year":"2012","unstructured":"Misra A, Kher G. Drug delivery systems from nose to brain. Curr Pharm Biotechnol. 2012;13(12):2355\u201379.","journal-title":"Curr Pharm Biotechnol"},{"issue":"3","key":"2613_CR36","doi-asserted-by":"publisher","first-page":"493","DOI":"10.1208\/s12248-015-9724-x","volume":"17","author":"MJ Ruigrok","year":"2015","unstructured":"Ruigrok MJ, de Lange EC. Emerging insights for translational pharmacokinetic and pharmacokinetic-Pharmacodynamic studies: towards prediction of nose-to-brain transport in humans. AAPS J. 2015;17(3):493\u2013505.","journal-title":"AAPS J"},{"issue":"8","key":"2613_CR37","doi-asserted-by":"publisher","first-page":"1146","DOI":"10.1248\/bpb.b17-00099","volume":"40","author":"N Nakamichi","year":"2017","unstructured":"Nakamichi N, Kato Y. Physiological roles of carnitine\/organic cation transporter OCTN1\/SLC22A4 in neural cells. Biol Pharm Bull. 2017;40(8):1146\u201352.","journal-title":"Biol Pharm Bull"},{"issue":"9","key":"2613_CR38","doi-asserted-by":"publisher","first-page":"3407","DOI":"10.1002\/jps.23595","volume":"102","author":"N Nakamichi","year":"2013","unstructured":"Nakamichi N, Shima H, Asano S, Ishimoto T, Sugiura T, Matsubara K, et al. Involvement of carnitine\/organic cation transporter OCTN1\/SLC22A4 in gastrointestinal absorption of metformin. J Pharm Sci. 2013;102(9):3407\u201317.","journal-title":"J Pharm Sci"},{"issue":"2","key":"2613_CR39","doi-asserted-by":"publisher","first-page":"153","DOI":"10.1007\/s00221-012-3356-5","volume":"225","author":"VA Schriever","year":"2013","unstructured":"Schriever VA, Reither N, Gerber J, Iannilli E, Hummel T. Olfactory bulb volume in smokers. Exp Brain Res. 2013;225(2):153\u20137.","journal-title":"Exp Brain Res"},{"issue":"8","key":"2613_CR40","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.biopsych.2007.03.001","volume":"62","author":"KP Cosgrove","year":"2007","unstructured":"Cosgrove KP, Mazure CM, Staley JK. Evolving knowledge of sex differences in brain structure, function, and chemistry. Biol Psychiatry. 2007;62(8):847\u201355.","journal-title":"Biol Psychiatry"},{"issue":"1","key":"2613_CR41","doi-asserted-by":"publisher","first-page":"59","DOI":"10.1080\/10611860601029496","volume":"15","author":"K Yamada","year":"2007","unstructured":"Yamada K, Hasegawa M, Kametani S, Ito S. Nose-to-brain delivery of TS-002, prostaglandin D2 analogue. J Drug Target. 2007;15(1):59\u201366.","journal-title":"J Drug Target"}],"container-title":["Pharmaceutical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11095-019-2613-8\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11095-019-2613-8.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,3,30]],"date-time":"2020-03-30T23:13:51Z","timestamp":1585610031000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11095-019-2613-8"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,4,1]]},"references-count":41,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2019,5]]}},"alternative-id":["2613"],"URL":"https:\/\/doi.org\/10.1007\/s11095-019-2613-8","relation":{},"ISSN":["0724-8741","1573-904X"],"issn-type":[{"value":"0724-8741","type":"print"},{"value":"1573-904X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,4,1]]},"assertion":[{"value":"15 November 2018","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"19 March 2019","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"1 April 2019","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}}],"article-number":"76"}}